These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Are COVID vaccination programmes working? Scientists seek first clues. Mallapaty S Nature; 2021 Jan; 589(7843):504-505. PubMed ID: 33483685 [No Abstract] [Full Text] [Related]
51. Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer. Ehmsen S; Asmussen A; Jeppesen SS; Nilsson AC; Østerlev S; Vestergaard H; Justesen US; Johansen IS; Frederiksen H; Ditzel HJ Cancer Cell; 2021 Aug; 39(8):1034-1036. PubMed ID: 34348121 [No Abstract] [Full Text] [Related]
52. COVID-19 vaccination in a cancerous patient: A comment. Mungmungpuntipantip R; Wiwanitkit V J Cancer Res Ther; 2021; 17(6):1587. PubMed ID: 34916404 [No Abstract] [Full Text] [Related]
53. Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older. Simone A; Herald J; Chen A; Gulati N; Shen AY; Lewin B; Lee MS JAMA Intern Med; 2021 Dec; 181(12):1668-1670. PubMed ID: 34605853 [TBL] [Abstract][Full Text] [Related]
54. Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study. Birabaharan M; Kaelber DC; Karris MY J Am Acad Dermatol; 2022 Sep; 87(3):649-651. PubMed ID: 34826538 [No Abstract] [Full Text] [Related]
55. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study. Shrotri M; Krutikov M; Palmer T; Giddings R; Azmi B; Subbarao S; Fuller C; Irwin-Singer A; Davies D; Tut G; Lopez Bernal J; Moss P; Hayward A; Copas A; Shallcross L Lancet Infect Dis; 2021 Nov; 21(11):1529-1538. PubMed ID: 34174193 [TBL] [Abstract][Full Text] [Related]
56. COVID vaccination studies: plan now to pool data, or be bogged down in confusion. Dean N Nature; 2021 Mar; 591(7849):179. PubMed ID: 33658668 [No Abstract] [Full Text] [Related]
57. Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma. Agarwal G; Moore S; Sadler R; Varghese S; Turner A; Chen LY; Larham J; Gray N; Carty O; Barrett J; Koshiaris C; Kothari J; Bowcock S; Oppermann U; Gamble V; Cook G; Kyriakou C; Drayson M; Basu S; McDonald S; McKinley S; Gooding S; Javaid MK; Ramasamy K Haematologica; 2024 Jun; 109(6):1960-1965. PubMed ID: 38268439 [No Abstract] [Full Text] [Related]
58. Excess mortality in Cyprus during the COVID-19 vaccination campaign. Economidou EC; Soteriades ES Vaccine; 2024 May; 42(15):3375-3376. PubMed ID: 37996289 [No Abstract] [Full Text] [Related]
59. COVID-19 vaccine intentions in Australia. Edwards B; Biddle N; Gray M; Sollis K Lancet Infect Dis; 2021 Dec; 21(12):1628-1629. PubMed ID: 34838220 [No Abstract] [Full Text] [Related]
60. How severe are Omicron infections? Ledford H Nature; 2021 Dec; 600(7890):577-578. PubMed ID: 34934198 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]